Barclays’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Barclays’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-609,546	Closed	-$8.89M	–	5333
2023 Q1	$8.89M	Buy	+609,546	New	+$8.61M	﹤0.01%	1218

Barclays's AMYT Position: Q2 2023 in Review

Barclays sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 609,546 shares — an estimated $8.89M sold.

Barclays first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $8.89M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Barclays reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Barclays sold 609,546 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $8.89M.
Barclays first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
Barclays's Amryt Pharma plc American Depositary Shares position peaked at $8.89M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.